Barclays PLC Portfolio Holdings

Barclays PLC

  • $377 Billion
  • Q3 2024

Barclays PLC has filed its 13F form on November 19, 2024 for Q3 2024 where it was disclosed a total value porftolio of $377 Billion distributed in 9207 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $13.4B, Microsoft Corp with a value of $13.2B, Nvidia Corp with a value of $11.9B, Amazon Com Inc with a value of $6.33B, and Alphabet Inc. with a value of $4.93B.

Examining the 13F form we can see an decrease of $14K in the current position value, from $377B to 377B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $377 Billion
ETFs: $135 Billion
Technology: $79.1 Billion
Consumer Cyclical: $29.9 Billion
Financial Services: $28.5 Billion
Communication Services: $22.6 Billion
Healthcare: $21.3 Billion
Industrials: $17.8 Billion
Consumer Defensive: $11.7 Billion
Other: $23.6 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Territorial Bancorp Inc
-
$148,000 0.0% of portfolio
-
Q3 2024 Added 5.55%
$2.15B
$7.89 Million 0.0% of portfolio
167,281
Q3 2024 Added 787.9%
Tetra Tech Inc New
-
$5.93 Million 0.0% of portfolio
-
Q3 2024 New
$491M
$650,000 0.0% of portfolio
209,873
Q3 2024 Added 369.63%
$0
$0 0.0% of portfolio
7
Q4 2023 Reduced 50.0%
$23.6B
$7.71 Million 0.0% of portfolio
427,595
Q3 2024 Added 31.67%
Tevogen Bio Hldgs Inc
-
$13,000 0.0% of portfolio
-
Q3 2024 Added 335.49%
$3.85B
$7.79 Million 0.0% of portfolio
108,950
Q3 2024 Added 19.61%
$9.34B
$17.6 Million 0.0% of portfolio
19,892
Q3 2024 Added 6.15%
$11.7B
$674,000 0.0% of portfolio
4,923
Q3 2024 Added 12.14%
$3.51B
$474,000 0.0% of portfolio
36,904
Q3 2024 Reduced 6.15%
$4.37B
$8.12 Million 0.0% of portfolio
347,057
Q3 2024 Added 149.08%
$311M
$403,000 0.0% of portfolio
40,542
Q3 2024 Added 280.32%
$2.41B
$5.43 Million 0.0% of portfolio
109,078
Q3 2024 Added 16.85%
The Beachbody Company Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$249M
$153,000 0.0% of portfolio
106,103
Q3 2024 Added 224.69%
$95.3M
$171,000 0.0% of portfolio
46,508
Q3 2024 Added 94.37%
$799M
$782,000 0.0% of portfolio
141,188
Q3 2024 Added 337.66%
$908M
$428,000 0.0% of portfolio
136,262
Q3 2024 Added 306.72%
$622M
$529,000 0.0% of portfolio
65,580
Q3 2024 Added 279.87%
Theriva Biologics Inc
-
$1,000 0.0% of portfolio
-
Q3 2024 New
$981M
$1.62 Million 0.0% of portfolio
54,149
Q3 2024 Added 312.09%
$446M
$426,000 0.0% of portfolio
15,929
Q3 2024 Added 254.61%
$445M
$393,000 0.0% of portfolio
29,012
Q3 2024 Added 181.62%
Thomson Reuters Corp.
-
$6.06 Million 0.0% of portfolio
-
Q3 2024 Reduced 35.47%
$5.19B
$9.55 Million 0.0% of portfolio
86,932
Q3 2024 Added 34.11%
$1.39B
$699,000 0.0% of portfolio
158,342
Q3 2024 Added 332.31%
$102M
$87,000 0.0% of portfolio
104,018
Q3 2024 Added 278.73%
$515M
$1.14 Million 0.0% of portfolio
66,126
Q3 2024 Added 397.0%
$2.58B
$5.66 Million 0.0% of portfolio
78,848
Q3 2024 Added 354.17%
$370M
$343,000 0.0% of portfolio
52,039
Q3 2024 Added 122.09%
$104M
$102,000 0.0% of portfolio
19,955
Q3 2024 Added 230.71%
$887M
$359,000 0.0% of portfolio
204,144
Q3 2024 Added 600.39%
$247M
$595,000 0.0% of portfolio
19,643
Q3 2024 Added 52.06%
$5.2B
$7.31 Million 0.0% of portfolio
86,667
Q3 2024 Added 221.57%
$729M
$1.42 Million 0.0% of portfolio
72,745
Q3 2024 Added 74.2%
$441M
$877,000 0.0% of portfolio
107,669
Q3 2024 Added 207.13%
$316M
$444,000 0.0% of portfolio
31,872
Q3 2024 Added 287.03%
$70.6M
$46,000 0.0% of portfolio
47,500
Q2 2024 Added 171.43%
$332M
$15,000 0.0% of portfolio
14,492
Q4 2023 Reduced 58.67%
$12.2B
$8.76 Million 0.0% of portfolio
309,426
Q3 2024 Added 37.98%
$978M
$1.5 Million 0.0% of portfolio
25,878
Q3 2024 Added 115.65%
$1.31B
$171,000 0.0% of portfolio
5,566
Q3 2024 Added 227.22%
$10.2B
$9.95 Million 0.0% of portfolio
24,447
Q3 2024 Reduced 13.98%
$3.94B
$3.23 Million 0.0% of portfolio
294,080
Q3 2024 Added 221.34%
$1.65B
$13.1 Million 0.0% of portfolio
384,308
Q3 2024 Added 65.39%
$97.6B
$13 Million 0.0% of portfolio
205,637
Q3 2024 Reduced 16.71%
$589M
$69,000 0.0% of portfolio
17,416
Q3 2024 Added 354.49%
Tourmaline Bio Inc
-
$819,000 0.0% of portfolio
-
Q3 2024 Added 283.67%

Summary

  • Portfolio
  • No. of Stocks 9,207
  • Current Value $377 Billion
  • Prior Value $377 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 19, 2024
  • Form Type 13F-HR/A
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email